LPD-12: a promising lipopeptide to control COVID-19

INTRODUCTION: : The recent pandemic outbreak of SARS-CoV-2 has been associated with a lethal atypical pneumonia, making COVID-19 an urgent public health issue with an increasing rate of mortality and morbidity. There are currently no vaccines or therapeutics available for COVID-19, which is causing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Trinath, Baindara, Piyush, Mandal, Santi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647407/
https://www.ncbi.nlm.nih.gov/pubmed/33166692
http://dx.doi.org/10.1016/j.ijantimicag.2020.106218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647407/
https://www.ncbi.nlm.nih.gov/pubmed/33166692
http://dx.doi.org/10.1016/j.ijantimicag.2020.106218

Ejemplares similares